Articles

Results 1 to 5 of 12
Most popular |Most recent


Big (But Not Bad) Data and Merger Efficiencies

USA - January 28 2020 Big data” has become one of the hottest subjects for antitrust enforcers around the globe. There is concern that large tech companies are amassing...

Gregory P. Luib.

Anticompetitive unilateral conduct in the pharmaceutical sector in USA

USA - September 6 2019 An overview of practical considerations surrounding abuse of dominance and other anticompetitive unilateral conduct in the pharmaceutical sector in USA, including IP rights abuse and pricing conduct....

Thomas J. Miller, Nicholas Passaro, George G. Gordon.

Anticompetitive agreements in the pharmaceutical sector in USA

USA - September 6 2019 An overview of essential considerations surrounding anticompetitive agreements in the pharmaceutical sector in USA, including the assessment framework and special issues with vertical agreements....

Thomas J. Miller, Nicholas Passaro, George G. Gordon.

Pharmaceutical antitrust law in USA

USA - September 6 2019 A structured guide to antitrust law in the pharmaceutical sector in USA, including the legislative and regulatory framework, merger review, anticompetitive agreements and abuse of dominance....

Thomas J. Miller, Nicholas Passaro, George G. Gordon.

US Court of Appeals Overturns LIBOR Convictions Based on Derivative Use of Compelled Testimony Lawfully Obtained in UK

USA, United Kingdom - September 1 2017 In a decision with significant implications for cross-border criminal and regulatory investigations in both the UK and U.S., a panel of the U.S. Court...

Matthew L. Mazur, Patrick Lyons, Lisa Foley, Matthew Banham.